GLP-1glp-1 receptor agonistsulcerative colitisinflammatory bowel disease

Inflammatory Bowel Diseases commentary calls GLP-1 colitis remission signal credible

The authors argue reported symptomatic remission in ulcerative colitis among GLP-1 receptor agonist users warrants prospective investigation.

By Maren Holt · Senior Reporter, GLP-1

Oct 15 20:00 ETSource: Inflammatory bowel diseases

The wire

01A commentary in Inflammatory Bowel Diseases describes the association between GLP-1 receptor agonists and symptomatic remission in ulcerative colitis as a credible signal.
02Gastroenterologists and prescribers managing patients on incretin drugs may face questions about effects on IBD disease activity.
03The piece is commentary, not new trial data, and the authors explicitly call for prospective study before conclusions are drawn.

From the source

GLP-1 receptor agonists and symptomatic remission in ulcerative colitis: A credible signal that welcomes prospective study
Inflammatory bowel diseases · 2026 Oct 16 · Alqinai B, Gayam S, Hadam-Veverka J et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42886561/